Comparison of Efficacy and Safety of Intravenous Labetalol Versus Hydralazine for Management of Severe Hypertension in Pregnancy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology
Link
http://link.springer.com/article/10.1007/s13224-017-1053-9/fulltext.html
Reference10 articles.
1. Lori JR, Strake AE. A critical analysis of maternal morbidity and mortality in Liberia, West Africa. Midwifery. 2012;25:67–72.
2. Magee LA, Abalos E, von Dadelszen P, et al. How to manage hypertension in pregnancy effectively. Br J Clin Pharmacol Soc. 2011;72:394–401.
3. Delgado De Pasquale S, Velarde R, Reyes O, et al. Hydralazine vs labetalol for the treatment of severe hypertensive disorders of pregnancy. A randomized, controlled trial. Pregnancy Hypertens. 2013;4(1):19–22.
4. Sharma KJ, Rodriguez M, Kilpatrick SJ, et al. Risks of parenteral antihypertensive therapy for the treatment of severe maternal hypertension are low. Hypertens Pregnancy. 2016;35(1):123–8.
5. Duley L, Meher S, Jones L. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev. 2013;7:CD001449. doi: 10.1002/14651858.CD001449.pub3 .
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Latest findings on labetalol in severe hypertension during pregnancy and in postpartum — a systematic review;Arterial Hypertension;2023-12-29
2. Republication de : recommandations formalisées d’experts. Prise en charge de la patiente avec une pré-éclampsie sévère;Anesthésie & Réanimation;2023-09
3. Comparing Intravenous Labetalol and Intravenous Hydralazine for Managing Severe Gestational Hypertension;Cureus;2023-07-23
4. Effectiveness of nifedipine, labetalol, and hydralazine as emergency antihypertension in severe preeclampsia: a randomized control trial;F1000Research;2023-04-27
5. Pharmaceutical administration for severe hypertension during pregnancy: Network meta-analysis;Frontiers in Pharmacology;2023-01-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3